Prokidney (PROK) Interest & Investment Income (2021 - 2026)
Prokidney's (PROK) quarterly Interest & Investment Income came in at $2.3 million in Q1 2026, down 42.22% year-on-year from $4.0 million in Q1 2025, and down 20.72% on a QoQ basis from $2.9 million in Q4 2025.
Prokidney (PROK) Interest & Investment Income (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Interest & Investment Income data on file, last reported at $2.3 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 42.22% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $12.1 million, a 36.03% decrease from a year earlier, with the FY2025 full-year figure at $13.8 million, down 30.07% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.3 million, down from $2.9 million in the prior quarter.
- Over the last five years, Interest & Investment Income for PROK reached as high as $6.0 million in Q2 2023 and fell as low as $1.6 million in Q3 2022.
- Historically, Interest & Investment Income has averaged $4.3 million across 5 years, with a median of $4.5 million in 2024.
- Across the five-year window, Interest & Investment Income jumped 52783.23% in 2022 and sank 42.22% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $4.4 million in 2022, then increased by 19.95% to $5.3 million in 2023, then dropped by 9.24% to $4.8 million in 2024, then sank by 38.75% to $2.9 million in 2025, then dropped by 20.72% to $2.3 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $2.3 million in Q1 2026, $2.9 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | 2.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Sep 30, 2024 | 5.58 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 4.84 Mn |
| Dec 31, 2023 | 5.28 Mn |
| Sep 30, 2023 | 5.54 Mn |
| Jun 30, 2023 | 5.97 Mn |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 4.40 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Dec 31, 2021 | 8,324.00 |
| Sep 30, 2021 | 3,042.00 |